Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Kenneth S Plante
Affiliation
University of Texas Medical Branch
ORCID
Career Start Year
2009
Papers
68
H Index
29
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36680235
Morphologic and Genetic Characterization of Ilheus Virus, a Potential Emergent Flavivirus in the Americas.
Viruses
2023
37896967
Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model.
Vaccines (Basel)
2023
37693415
SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection.
bioRxiv
2023
37460536
Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.
Nat Commun
2023
37131784
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection.
bioRxiv
2023
36680235
Morphologic and Genetic Characterization of Ilheus Virus, a Potential Emergent Flavivirus in the Americas.
Viruses
2023
37425880
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication.
bioRxiv
2023
36722972
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol
2023
37896967
Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model.
Vaccines (Basel)
2023
37693415
SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infection.
bioRxiv
2023
37460536
Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters.
Nat Commun
2023
37425880
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication.
bioRxiv
2023
37131784
Loss-of-function mutation in Omicron variants reduces spike protein expression and attenuates SARS-CoV-2 infection.
bioRxiv
2023
36722972
SARS-CoV-2 Uses Nonstructural Protein 16 To Evade Restriction by IFIT1 and IFIT3.
J Virol
2023
34818667
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
Nature
2022
36103514
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.
Sci Transl Med
2022
36229471
Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Nat Commun
2022
35896528
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Nat Commun
2022
36013996
Yellow Fever: Roles of Animal Models and Arthropod Vector Studies in Understanding Epidemic Emergence.
Microorganisms
2022
35881779
QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
Proc Natl Acad Sci U S A
2022
36146877
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
Viruses
2022
36203546
SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3.
bioRxiv
2022
35926067
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif.
Sci Immunol
2022
35728038
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
PLoS Pathog
2022
33736732
Outbreak of coronavirus disease 2019 (COVID-19) among operating room staff of a tertiary referral center: An epidemiologic and environmental investigation.
Infect Control Hosp Epidemiol
2022
34671771
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
bioRxiv
2022
34818667
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission.
Nature
2022
34929721
VLDLR and ApoER2 are receptors for multiple alphaviruses.
Nature
2022
35728038
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
PLoS Pathog
2022
36146877
Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients.
Viruses
2022
36103514
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.
Sci Transl Med
2022
36203546
SARS-CoV-2 Uses Nonstructural Protein 16 to Evade Restriction by IFIT1 and IFIT3.
bioRxiv
2022
35896528
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Nat Commun
2022
36229471
Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.
Nat Commun
2022
35926067
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif.
Sci Immunol
2022
36013996
Yellow Fever: Roles of Animal Models and Arthropod Vector Studies in Understanding Epidemic Emergence.
Microorganisms
2022
35881779
QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis.
Proc Natl Acad Sci U S A
2022
33736732
Outbreak of coronavirus disease 2019 (COVID-19) among operating room staff of a tertiary referral center: An epidemiologic and environmental investigation.
Infect Control Hosp Epidemiol
2022
34929721
VLDLR and ApoER2 are receptors for multiple alphaviruses.
Nature
2022
34671771
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
bioRxiv
2022
33106671
Spike mutation D614G alters SARS-CoV-2 fitness.
Nature
2021
33494095
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
Nature
2021
33691138
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.
Cell
2021
33539255
Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models.
Emerg Microbes Infect
2021
33789086
The variant gambit: COVID-19's next move.
Cell Host Microbe
2021
33721754
Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Biomed Pharmacother
2021
33873199
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Nature
2021
33823988
Designing multivalent immunogens for alphavirus vaccine optimization.
Virology
2021
33501436
A <i>trans</i> -complementation system for SARS-CoV-2.
bioRxiv
2021
33500409
Role of mutational reversions and fitness restoration in Zika virus spread to the Americas.
Nat Commun
2021
1 - 50 of 136
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
5
Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year
2017
Number of shared co-authors
0
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
0
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year
2015
Number of shared co-authors
2
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2015
Number of shared co-authors
0
Stuart Weston
University of Maryland School of Medicine
Career Start Year
2014
Number of shared co-authors
6
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year
2013
Number of shared co-authors
1
Nathan D Grubaugh
Yale School of Public Health
Career Start Year
2013
Number of shared co-authors
1
Romel Rosales
Icahn School of Medicine at Mount Sinai
Career Start Year
2012
Number of shared co-authors
1
Shashank Tripathi
Indian Institute of Science
Career Start Year
2011
Number of shared co-authors
3
Meagan E Deming
University of Maryland School of Medicine
Career Start Year
2011
Number of shared co-authors
10
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
5
Velmurugan Balaraman
College of Veterinary Medicine, Kansas State University
Career Start Year
2009
Number of shared co-authors
0
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
4
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year
2007
Number of shared co-authors
0
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year
2005
Number of shared co-authors
18
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
5
Rachel L Graham
University of North Carolina
Career Start Year
2004
Number of shared co-authors
17
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year
2004
Number of shared co-authors
3
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year
2002
Number of shared co-authors
2
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year
2001
Number of shared co-authors
3
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year
1998
Number of shared co-authors
17
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
1998
Number of shared co-authors
12
Gary P Kobinger
University of Texas Medical Branch
Career Start Year
1997
Number of shared co-authors
4
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
15
James D Chappell
Vanderbilt University Medical Center
Career Start Year
1995
Number of shared co-authors
6
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
1993
Number of shared co-authors
21
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
1
James E Strong
University of Manitoba
Career Start Year
1991
Number of shared co-authors
0
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
13
row(s) 1 - 30 of 30
Collaborators
Jessica A Plante
Co-authored papers
45
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers
30
Pei-Yong Shi
University of Texas Medical Branch
Co-authored papers
19
Xuping Xie
University of Texas Medical Branch
Co-authored papers
17
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Co-authored papers
8
Hongjie Xia
University of Texas Medical Branch
Co-authored papers
8
Zhiqiang An
Zhengzhou University
Co-authored papers
8
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers
8
Clayton R Morrison
University of North Carolina School of Medicine
Co-authored papers
6
Steven G Widen
University of Texas Medical Branch
Co-authored papers
6
Alexander N Freiberg
University of Texas Medical Branch
Co-authored papers
6
Kasi E Russell-Lodrigue
Co-authored papers
5
Ralph S Baric
University of North Carolina
Co-authored papers
5
Mehul S Suthar
Co-authored papers
5
Rudolf P Bohm
Co-authored papers
4
Jay Rappaport
Co-authored papers
4
Nicholas J Maness
Co-authored papers
4
Nadia A Golden
Co-authored papers
4
Chad J Roy
Co-authored papers
4
Chad J Roy
Co-authored papers
3
Pyone P Aye
Co-authored papers
3
Martin T Ferris
University of North Carolina.
Co-authored papers
3
David C Montefiori
Co-authored papers
3
Christopher Monjure
Co-authored papers
3
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers
3
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers
3
Lara A Doyle-Meyers
Co-authored papers
3
Ande West
University of North Carolina at Chapel Hill
Co-authored papers
2
Stephanie Fischinger
Co-authored papers
2
Mary Jane Navarro
Co-authored papers
2
1 - 30